Table 2.
List of perpetrator medications responsible for CYP2D6, CYP2C19 and CYP2C9 phenoconversion identified at admission and discharge.
| Medication | No. of Patients | Inhibitor | Inducer | Affected Enzyme(s) | |
|---|---|---|---|---|---|
| Admission | Discharge | ||||
| Amiodarone | 3 | 3 | ✓ (M) | CYP2C9 | |
| Carbamazepine | 3 | 3 | ✓ | CYP2C9, CYP2C19 | |
| Duloxetine | 11 | 13 | ✓ (M) | CYP2D6 | |
| Esomeprazole | 19 | 17 | ✓ (M) | CYP2C19 | |
| Fluoxetine | 2 | 1 | ✓ (S) | CYP2D6 | |
| ✓ (M) | CYP2C19 | ||||
| Omeprazole | 4 | 4 | ✓ (M) | CYP2C19 | |
| Paroxetine | 2 | 2 | ✓ (S) | CYP2D6 | |
| Sertraline | 15 | 17 | ✓ (M) | CYP2D6 | |
| Terbinafine | 1 | 0 | ✓ (M) | CYP2D6 | |
The CYP inhibitor or inducer effect of each medication is listed along with the affected enzyme(s).
(S), Strong inhibitor; (M), Moderate inhibitor.